NCI COMPASS
Comprehensive Oncologic Molecular Pathology and Sequencing Service
The Laboratory of Pathology (LP), NCI, has implemented the Comprehensive Oncologic Molecular Pathology and Sequencing Service (NCI-COMPASS). The goal of NCI-COMPASS is to provide state of the art clinical sequencing services to CCR PIs. To this end, the NCI-COMPASS program is developing large NGS panels, as well as additional cancer -omics technologies to establish a CLIA-certified and College of American Pathologists (CAP)-accredited program to support precision cancer diagnostics (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5707196/). An example of this effort includes the recently established methylation classifier program for cancer diagnostics, first launched for brain tumors, to be extended to additional tumor types in the future.
Services Under the COMPASS Program Include:
| Clinical Molecular Testing Core | Clinical Next Gen Sequencing Unit | Clinical Methylation Unit | Clinical Bioinformatics Unit |
|---|
Overview
Content Tools
ThemeBuilder